Published in J Med Virol on April 01, 1987
Diagnosing rubella. BMJ (1989) 1.50
Erythema infectiosum and pregnancy-related complications. CMAJ (1990) 1.40
Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19. J Clin Microbiol (1991) 0.93
Serologically proven acute rubella infection in patients with clinical diagnosis of dengue. Epidemiol Infect (1990) 0.82
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs. Vaccines (Basel) (2015) 0.75
Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) (1983) 4.13
Human parvovirus arthropathy. Lancet (1985) 3.76
An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) (1984) 3.38
Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet (1998) 2.31
Electron microscopy of hepatitis B core antigen synthesized in E. coli. Nature (1982) 2.25
Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med (1987) 2.23
Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol (1993) 2.18
Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest (1989) 2.08
Enzyme-linked immunosorbent assays based on polyclonal and monoclonal antibodies for rotavirus detection. J Clin Microbiol (1984) 2.03
Mitigation of experimental inflammatory bowel disease in guinea pigs by selective elimination of the aerobic gram-negative intestinal microflora. Gastroenterology (1974) 1.95
Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol (1998) 1.88
Application of a screening test for antibody the hepatitis B core antigen. J Clin Pathol (1977) 1.85
The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol (1988) 1.80
Comparison of radioimmunoassay and counter-immunoelectrophoresis for the detection of antibody to hepatitis B core antigen. J Virol Methods (1981) 1.65
Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med (1989) 1.55
Human parvovirus and the fetus. Lancet (1985) 1.50
Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann Rheum Dis (1986) 1.47
An outbreak of rotavirus diarrhea among a nonimmune, isolated South American Indian community. Am J Epidemiol (1981) 1.43
The effects of relative humidity and temperature on the survival of human rotavirus in faeces. Arch Virol (1982) 1.43
Revisiting carotid sinus denervation in carotid sinus hypersensitivity. Am Heart J (1994) 1.40
Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ (2001) 1.40
The IgM antibody responses to the core antigen of hepatitis B virus. J Med Virol (1978) 1.39
Colonization patterns of aerobic gram-negative bacteria in the cloaca of Rana pipiens. Lab Anim Sci (1974) 1.38
A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health (2001) 1.37
Transdermal Nicotine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs (1992) 1.34
Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs (1992) 1.33
Hepatitis C virus antibody. Lancet (1989) 1.33
Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis (1995) 1.31
The influence of divalent cations on the stability of human rotavirus. Arch Virol (1981) 1.28
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol (1993) 1.24
Haemagglutination by parvovirus B19. J Gen Virol (1992) 1.23
Structure and mapping of the DNA of human parvovirus B19. J Gen Virol (1987) 1.19
Dot blot hybridization assay of B19 virus DNA in clinical specimens. J Clin Microbiol (1989) 1.18
Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs (1991) 1.17
More cases of SIADH with fluoxetine. Am J Psychiatry (1990) 1.17
Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet (1983) 1.15
Clinical predictors of acute coronary syndromes in patients with undifferentiated chest pain. QJM (2003) 1.09
Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev (2002) 1.09
Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs (1991) 1.09
Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Methods (1993) 1.08
Laboratory infection with parvovirus B19. J Clin Pathol (1988) 1.07
Septoplasty complicated by staphylococcal spinal osteomyelitis. Arch Intern Med (1985) 1.05
Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991-4. Epidemiol Infect (1998) 1.05
Primary liver cell cancer in Britain--a viral aetiology? Br Med J (1979) 1.02
Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in São Paulo, Brazil. Trans R Soc Trop Med Hyg (1995) 1.02
Nakatani antigen and human parvovirus (B19) Lancet (1984) 1.00
Human parvovirus induced cytopenias: a report of five cases. Br J Haematol (1986) 1.00
Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev (1994) 0.99
Home nebulizers in severe chronic asthma. Br J Dis Chest (1984) 0.99
Detection of parvovirus B19 DNA, antigen, and particles in the human fetus. J Med Virol (1987) 0.98
Wound repair in mice as influenced by age and antimacrophage serum. J Gerontol (1987) 0.97
Detection of IgG antibody to Epstein-Barr virus viral capsid antigen in saliva by antibody capture radioimmunoassay. J Virol Methods (1997) 0.97
The value of screening blood donors for antibody to hepatitis B core antigen. J Clin Pathol (1983) 0.97
Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol (1994) 0.96
HLA and acute arthritis following human parvovirus infection. Tissue Antigens (1986) 0.96
Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted diseases. J Hyg (Lond) (1984) 0.96
Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases. Drugs (1993) 0.96
Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the non-structural protein. Arch Virol (1996) 0.95
Human parvovirus (B19) and erythema infectiosum. J Pediatr (1985) 0.95
Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient. Br J Haematol (1989) 0.95
Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods (1999) 0.95
Dual infection with rubella and human parvovirus. Lancet (1985) 0.94
Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang (1990) 0.94
A novel assay for hepatitis B e markers. J Med Virol (1997) 0.93
Detection of rubella virus-specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate. J Clin Microbiol (1999) 0.93
Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19. J Clin Microbiol (1991) 0.93
Anemia and menstrual blood loss. Obstet Gynecol Surv (1980) 0.92
Human parvovirus B19 infected fetal liver as a source of antigen for a radioimmunoassay for B19 specific IgM in clinical samples. J Med Virol (1991) 0.92
Neuralgic amyotrophy due to parvovirus infection. J Neurol Neurosurg Psychiatry (1987) 0.92
Measles virus strains circulating in Ethiopia in 1998-1999: molecular characterisation using oral fluid samples and identification of a new genotype. J Med Virol (2001) 0.92
An enzyme-linked immunosorbent-assay test for hepatitis B surface antigen. J Clin Pathol (1977) 0.91
Absence of bacteremia during nasal septoplasty. Arch Otolaryngol Head Neck Surg (1991) 0.91
Folded BOXCARS for rotational Raman studies. Opt Lett (1980) 0.90
Delta agent in Britain. Lancet (1983) 0.90
Erythema infectiosum in a village primary school: clinical and virological studies. J R Coll Gen Pract (1986) 0.90
The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo (1991) 0.89
In vitro propagation of parvovirus B19 in primary foetal liver culture. J Gen Virol (1991) 0.89
Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile. Drugs (1990) 0.89
Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs (1991) 0.89
Surgical prophylaxis of malignant melanoma. Ann Surg (1991) 0.88
Changing the method of selection at Northwick Park. Br Med J (Clin Res Ed) (1982) 0.87
Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens. J Clin Microbiol (1994) 0.87
Antibody capture haemadherence tests for parvovirus B19-specific IgM and IgG. J Virol Methods (1993) 0.86
Accelerated wound repair in old deer mice (Peromyscus maniculatus) and white-footed mice (Peromyscus leucopus). J Gerontol (1987) 0.86
Parvovirus B19 outbreak on an adult ward. Epidemiol Infect (1994) 0.86
Detection of B19 parvovirus in human fetal tissues by electron microscopy. J Med Virol (1991) 0.86
Human serum parvovirus as the cause of aplastic crisis in sickle cell disease. Am J Dis Child (1984) 0.85
Secondary infection with parvovirus B19 in an HIV-positive patient. AIDS (1993) 0.85
The anti-HBc IgM response in the acute and convalescent phases of acute hepatitis. J Infect (1981) 0.85
Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs (1990) 0.84
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs (1992) 0.84
Detection of B19 parvovirus in human fetal tissues by in situ hybridisation. J Med Virol (1991) 0.84
Age-associated lesions in barrier-reared male Sprague-Dawley rats: a comparison between Hap: (SD) and Crl:COBS[R]CD[R](SD) stocks. Exp Aging Res (1982) 0.83
Strain-specific renal toxicity of heterologous antilymphocyte gamma-globulin in mice. Transplantation (1970) 0.81
A simple and sensitive DNA hybridization assay used for the routine diagnosis of human parvovirus B19 infection. J Clin Microbiol (1995) 0.81